The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Targeted Protein Degradation Drug Market Research Report 2025

Global Targeted Protein Degradation Drug Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1935398

No of Pages : 88

Synopsis
The global Targeted Protein Degradation Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Targeted Protein Degradation Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Targeted Protein Degradation Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Targeted Protein Degradation Drug in Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Targeted Protein Degradation Drug include Arvinas, Kangpu Biopharmaceuticals, Ranok Therapeutics, Accutar Biotechnology, BeiGene Ltd., Hinova Pharmaceuticals, Haisco Pharmaceutical, Nurix and Kymera Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Targeted Protein Degradation Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Protein Degradation Drug.
Report Scope
The Targeted Protein Degradation Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted Protein Degradation Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Protein Degradation Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Arvinas
Kangpu Biopharmaceuticals
Ranok Therapeutics
Accutar Biotechnology
BeiGene Ltd.
Hinova Pharmaceuticals
Haisco Pharmaceutical
Nurix
Kymera Therapeutics
C4 Therapeutics
Segment by Type
PROTAC
Molecular Glue
Segment by Application
Cancer
Autoimmune Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Protein Degradation Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Protein Degradation Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PROTAC
1.2.3 Molecular Glue
1.3 Market by Application
1.3.1 Global Targeted Protein Degradation Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Protein Degradation Drug Market Perspective (2019-2030)
2.2 Targeted Protein Degradation Drug Growth Trends by Region
2.2.1 Global Targeted Protein Degradation Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Targeted Protein Degradation Drug Historic Market Size by Region (2019-2024)
2.2.3 Targeted Protein Degradation Drug Forecasted Market Size by Region (2025-2030)
2.3 Targeted Protein Degradation Drug Market Dynamics
2.3.1 Targeted Protein Degradation Drug Industry Trends
2.3.2 Targeted Protein Degradation Drug Market Drivers
2.3.3 Targeted Protein Degradation Drug Market Challenges
2.3.4 Targeted Protein Degradation Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Protein Degradation Drug Players by Revenue
3.1.1 Global Top Targeted Protein Degradation Drug Players by Revenue (2019-2024)
3.1.2 Global Targeted Protein Degradation Drug Revenue Market Share by Players (2019-2024)
3.2 Global Targeted Protein Degradation Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Targeted Protein Degradation Drug Revenue
3.4 Global Targeted Protein Degradation Drug Market Concentration Ratio
3.4.1 Global Targeted Protein Degradation Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Protein Degradation Drug Revenue in 2023
3.5 Targeted Protein Degradation Drug Key Players Head office and Area Served
3.6 Key Players Targeted Protein Degradation Drug Product Solution and Service
3.7 Date of Enter into Targeted Protein Degradation Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Protein Degradation Drug Breakdown Data by Type
4.1 Global Targeted Protein Degradation Drug Historic Market Size by Type (2019-2024)
4.2 Global Targeted Protein Degradation Drug Forecasted Market Size by Type (2025-2030)
5 Targeted Protein Degradation Drug Breakdown Data by Application
5.1 Global Targeted Protein Degradation Drug Historic Market Size by Application (2019-2024)
5.2 Global Targeted Protein Degradation Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Targeted Protein Degradation Drug Market Size (2019-2030)
6.2 North America Targeted Protein Degradation Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Targeted Protein Degradation Drug Market Size by Country (2019-2024)
6.4 North America Targeted Protein Degradation Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Protein Degradation Drug Market Size (2019-2030)
7.2 Europe Targeted Protein Degradation Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Targeted Protein Degradation Drug Market Size by Country (2019-2024)
7.4 Europe Targeted Protein Degradation Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Protein Degradation Drug Market Size (2019-2030)
8.2 Asia-Pacific Targeted Protein Degradation Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Targeted Protein Degradation Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Targeted Protein Degradation Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Protein Degradation Drug Market Size (2019-2030)
9.2 Latin America Targeted Protein Degradation Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Targeted Protein Degradation Drug Market Size by Country (2019-2024)
9.4 Latin America Targeted Protein Degradation Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Protein Degradation Drug Market Size (2019-2030)
10.2 Middle East & Africa Targeted Protein Degradation Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Targeted Protein Degradation Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Targeted Protein Degradation Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arvinas
11.1.1 Arvinas Company Detail
11.1.2 Arvinas Business Overview
11.1.3 Arvinas Targeted Protein Degradation Drug Introduction
11.1.4 Arvinas Revenue in Targeted Protein Degradation Drug Business (2019-2024)
11.1.5 Arvinas Recent Development
11.2 Kangpu Biopharmaceuticals
11.2.1 Kangpu Biopharmaceuticals Company Detail
11.2.2 Kangpu Biopharmaceuticals Business Overview
11.2.3 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Introduction
11.2.4 Kangpu Biopharmaceuticals Revenue in Targeted Protein Degradation Drug Business (2019-2024)
11.2.5 Kangpu Biopharmaceuticals Recent Development
11.3 Ranok Therapeutics
11.3.1 Ranok Therapeutics Company Detail
11.3.2 Ranok Therapeutics Business Overview
11.3.3 Ranok Therapeutics Targeted Protein Degradation Drug Introduction
11.3.4 Ranok Therapeutics Revenue in Targeted Protein Degradation Drug Business (2019-2024)
11.3.5 Ranok Therapeutics Recent Development
11.4 Accutar Biotechnology
11.4.1 Accutar Biotechnology Company Detail
11.4.2 Accutar Biotechnology Business Overview
11.4.3 Accutar Biotechnology Targeted Protein Degradation Drug Introduction
11.4.4 Accutar Biotechnology Revenue in Targeted Protein Degradation Drug Business (2019-2024)
11.4.5 Accutar Biotechnology Recent Development
11.5 BeiGene Ltd.
11.5.1 BeiGene Ltd. Company Detail
11.5.2 BeiGene Ltd. Business Overview
11.5.3 BeiGene Ltd. Targeted Protein Degradation Drug Introduction
11.5.4 BeiGene Ltd. Revenue in Targeted Protein Degradation Drug Business (2019-2024)
11.5.5 BeiGene Ltd. Recent Development
11.6 Hinova Pharmaceuticals
11.6.1 Hinova Pharmaceuticals Company Detail
11.6.2 Hinova Pharmaceuticals Business Overview
11.6.3 Hinova Pharmaceuticals Targeted Protein Degradation Drug Introduction
11.6.4 Hinova Pharmaceuticals Revenue in Targeted Protein Degradation Drug Business (2019-2024)
11.6.5 Hinova Pharmaceuticals Recent Development
11.7 Haisco Pharmaceutical
11.7.1 Haisco Pharmaceutical Company Detail
11.7.2 Haisco Pharmaceutical Business Overview
11.7.3 Haisco Pharmaceutical Targeted Protein Degradation Drug Introduction
11.7.4 Haisco Pharmaceutical Revenue in Targeted Protein Degradation Drug Business (2019-2024)
11.7.5 Haisco Pharmaceutical Recent Development
11.8 Nurix
11.8.1 Nurix Company Detail
11.8.2 Nurix Business Overview
11.8.3 Nurix Targeted Protein Degradation Drug Introduction
11.8.4 Nurix Revenue in Targeted Protein Degradation Drug Business (2019-2024)
11.8.5 Nurix Recent Development
11.9 Kymera Therapeutics
11.9.1 Kymera Therapeutics Company Detail
11.9.2 Kymera Therapeutics Business Overview
11.9.3 Kymera Therapeutics Targeted Protein Degradation Drug Introduction
11.9.4 Kymera Therapeutics Revenue in Targeted Protein Degradation Drug Business (2019-2024)
11.9.5 Kymera Therapeutics Recent Development
11.10 C4 Therapeutics
11.10.1 C4 Therapeutics Company Detail
11.10.2 C4 Therapeutics Business Overview
11.10.3 C4 Therapeutics Targeted Protein Degradation Drug Introduction
11.10.4 C4 Therapeutics Revenue in Targeted Protein Degradation Drug Business (2019-2024)
11.10.5 C4 Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Targeted Protein Degradation Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of PROTAC
Table 3. Key Players of Molecular Glue
Table 4. Global Targeted Protein Degradation Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Targeted Protein Degradation Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Targeted Protein Degradation Drug Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Targeted Protein Degradation Drug Market Share by Region (2019-2024)
Table 8. Global Targeted Protein Degradation Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Targeted Protein Degradation Drug Market Share by Region (2025-2030)
Table 10. Targeted Protein Degradation Drug Market Trends
Table 11. Targeted Protein Degradation Drug Market Drivers
Table 12. Targeted Protein Degradation Drug Market Challenges
Table 13. Targeted Protein Degradation Drug Market Restraints
Table 14. Global Targeted Protein Degradation Drug Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Targeted Protein Degradation Drug Market Share by Players (2019-2024)
Table 16. Global Top Targeted Protein Degradation Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Protein Degradation Drug as of 2023)
Table 17. Ranking of Global Top Targeted Protein Degradation Drug Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Targeted Protein Degradation Drug Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Targeted Protein Degradation Drug Product Solution and Service
Table 21. Date of Enter into Targeted Protein Degradation Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Targeted Protein Degradation Drug Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Targeted Protein Degradation Drug Revenue Market Share by Type (2019-2024)
Table 25. Global Targeted Protein Degradation Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Targeted Protein Degradation Drug Revenue Market Share by Type (2025-2030)
Table 27. Global Targeted Protein Degradation Drug Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Targeted Protein Degradation Drug Revenue Market Share by Application (2019-2024)
Table 29. Global Targeted Protein Degradation Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Targeted Protein Degradation Drug Revenue Market Share by Application (2025-2030)
Table 31. North America Targeted Protein Degradation Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Targeted Protein Degradation Drug Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Targeted Protein Degradation Drug Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Targeted Protein Degradation Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Targeted Protein Degradation Drug Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Targeted Protein Degradation Drug Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Targeted Protein Degradation Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Targeted Protein Degradation Drug Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Targeted Protein Degradation Drug Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Targeted Protein Degradation Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Targeted Protein Degradation Drug Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Targeted Protein Degradation Drug Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Targeted Protein Degradation Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Targeted Protein Degradation Drug Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Targeted Protein Degradation Drug Market Size by Country (2025-2030) & (US$ Million)
Table 46. Arvinas Company Detail
Table 47. Arvinas Business Overview
Table 48. Arvinas Targeted Protein Degradation Drug Product
Table 49. Arvinas Revenue in Targeted Protein Degradation Drug Business (2019-2024) & (US$ Million)
Table 50. Arvinas Recent Development
Table 51. Kangpu Biopharmaceuticals Company Detail
Table 52. Kangpu Biopharmaceuticals Business Overview
Table 53. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product
Table 54. Kangpu Biopharmaceuticals Revenue in Targeted Protein Degradation Drug Business (2019-2024) & (US$ Million)
Table 55. Kangpu Biopharmaceuticals Recent Development
Table 56. Ranok Therapeutics Company Detail
Table 57. Ranok Therapeutics Business Overview
Table 58. Ranok Therapeutics Targeted Protein Degradation Drug Product
Table 59. Ranok Therapeutics Revenue in Targeted Protein Degradation Drug Business (2019-2024) & (US$ Million)
Table 60. Ranok Therapeutics Recent Development
Table 61. Accutar Biotechnology Company Detail
Table 62. Accutar Biotechnology Business Overview
Table 63. Accutar Biotechnology Targeted Protein Degradation Drug Product
Table 64. Accutar Biotechnology Revenue in Targeted Protein Degradation Drug Business (2019-2024) & (US$ Million)
Table 65. Accutar Biotechnology Recent Development
Table 66. BeiGene Ltd. Company Detail
Table 67. BeiGene Ltd. Business Overview
Table 68. BeiGene Ltd. Targeted Protein Degradation Drug Product
Table 69. BeiGene Ltd. Revenue in Targeted Protein Degradation Drug Business (2019-2024) & (US$ Million)
Table 70. BeiGene Ltd. Recent Development
Table 71. Hinova Pharmaceuticals Company Detail
Table 72. Hinova Pharmaceuticals Business Overview
Table 73. Hinova Pharmaceuticals Targeted Protein Degradation Drug Product
Table 74. Hinova Pharmaceuticals Revenue in Targeted Protein Degradation Drug Business (2019-2024) & (US$ Million)
Table 75. Hinova Pharmaceuticals Recent Development
Table 76. Haisco Pharmaceutical Company Detail
Table 77. Haisco Pharmaceutical Business Overview
Table 78. Haisco Pharmaceutical Targeted Protein Degradation Drug Product
Table 79. Haisco Pharmaceutical Revenue in Targeted Protein Degradation Drug Business (2019-2024) & (US$ Million)
Table 80. Haisco Pharmaceutical Recent Development
Table 81. Nurix Company Detail
Table 82. Nurix Business Overview
Table 83. Nurix Targeted Protein Degradation Drug Product
Table 84. Nurix Revenue in Targeted Protein Degradation Drug Business (2019-2024) & (US$ Million)
Table 85. Nurix Recent Development
Table 86. Kymera Therapeutics Company Detail
Table 87. Kymera Therapeutics Business Overview
Table 88. Kymera Therapeutics Targeted Protein Degradation Drug Product
Table 89. Kymera Therapeutics Revenue in Targeted Protein Degradation Drug Business (2019-2024) & (US$ Million)
Table 90. Kymera Therapeutics Recent Development
Table 91. C4 Therapeutics Company Detail
Table 92. C4 Therapeutics Business Overview
Table 93. C4 Therapeutics Targeted Protein Degradation Drug Product
Table 94. C4 Therapeutics Revenue in Targeted Protein Degradation Drug Business (2019-2024) & (US$ Million)
Table 95. C4 Therapeutics Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted Protein Degradation Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Targeted Protein Degradation Drug Market Share by Type: 2023 VS 2030
Figure 3. PROTAC Features
Figure 4. Molecular Glue Features
Figure 5. Global Targeted Protein Degradation Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Targeted Protein Degradation Drug Market Share by Application: 2023 VS 2030
Figure 7. Cancer Case Studies
Figure 8. Autoimmune Diseases Case Studies
Figure 9. Other Case Studies
Figure 10. Targeted Protein Degradation Drug Report Years Considered
Figure 11. Global Targeted Protein Degradation Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Targeted Protein Degradation Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Targeted Protein Degradation Drug Market Share by Region: 2023 VS 2030
Figure 14. Global Targeted Protein Degradation Drug Market Share by Players in 2023
Figure 15. Global Top Targeted Protein Degradation Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Protein Degradation Drug as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Targeted Protein Degradation Drug Revenue in 2023
Figure 17. North America Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Targeted Protein Degradation Drug Market Share by Country (2019-2030)
Figure 19. United States Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Targeted Protein Degradation Drug Market Share by Country (2019-2030)
Figure 23. Germany Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Targeted Protein Degradation Drug Market Share by Region (2019-2030)
Figure 31. China Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Targeted Protein Degradation Drug Market Share by Country (2019-2030)
Figure 39. Mexico Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Targeted Protein Degradation Drug Market Share by Country (2019-2030)
Figure 43. Turkey Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Targeted Protein Degradation Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Arvinas Revenue Growth Rate in Targeted Protein Degradation Drug Business (2019-2024)
Figure 46. Kangpu Biopharmaceuticals Revenue Growth Rate in Targeted Protein Degradation Drug Business (2019-2024)
Figure 47. Ranok Therapeutics Revenue Growth Rate in Targeted Protein Degradation Drug Business (2019-2024)
Figure 48. Accutar Biotechnology Revenue Growth Rate in Targeted Protein Degradation Drug Business (2019-2024)
Figure 49. BeiGene Ltd. Revenue Growth Rate in Targeted Protein Degradation Drug Business (2019-2024)
Figure 50. Hinova Pharmaceuticals Revenue Growth Rate in Targeted Protein Degradation Drug Business (2019-2024)
Figure 51. Haisco Pharmaceutical Revenue Growth Rate in Targeted Protein Degradation Drug Business (2019-2024)
Figure 52. Nurix Revenue Growth Rate in Targeted Protein Degradation Drug Business (2019-2024)
Figure 53. Kymera Therapeutics Revenue Growth Rate in Targeted Protein Degradation Drug Business (2019-2024)
Figure 54. C4 Therapeutics Revenue Growth Rate in Targeted Protein Degradation Drug Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’